Literature DB >> 10026026

Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.

A C Rosen1, M Klein, E Hafner, M Lahousen, A H Graf, A Reiner.   

Abstract

We retrospectively analyzed 143 women treated in 28 departments from 1980 to 1995, to study the impact of prognostic factors in primary carcinoma of the fallopian tube. Further aims of the study were to evaluate the treatment of fallopian tube carcinoma in Austria. Staging of disease was done according to the modified FIGO system, and grading according to the criteria suggested by Hu et al. The mean age of the patients was 62.5 years. Sixty (42%) tumors were found to be in stage I, 28 (19%) in stage II, 38 (27%) in stage III, and 17 (12%) in stage IV. Radical resection was achieved in 102 (71%) patients. In 122 (85%) women surgery involved removal of the uterus, the adnexa, and/or the omentum or lymph nodes. Postoperatively patients underwent adjuvant therapy consisting of either irradiation (n = 40; 28%) or chemotherapy (n = 70; 49%); 33 women (23%) did not receive any treatment after surgery. The 5-year survival rate for all stages of disease was 43%. The 5-year survival rate was 59% for stages I and II and 19% for stages III and IV. FIGO stage, histologic grading and residual tumor showed an independent prognostic impact in multivariate analysis.

Entities:  

Mesh:

Year:  1999        PMID: 10026026     DOI: 10.1159/000010061

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

Review 1.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

2.  Small fallopian tube carcinoma with extensive upper abdominal dissemination: a case report.

Authors:  Carolina Oliveira; Hálio Duarte; Carla Bartosch; Daniel Fernandes
Journal:  J Med Case Rep       Date:  2013-11-07

3. 

Authors:  Nisrine Mamouni; Hanane Saadi; Hinde Belfatemi; Sanaa Erraghay; Chahrazade Bouchikhi; Abdelaziz Banani
Journal:  Pan Afr Med J       Date:  2017-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.